Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMQ
2101
Trilogy Metals
TMQ
$643M
| $2.29M | ﹤0.01% |
2,418,180
-84,333
| -3% | -$83.3K |
|
2102
ResMed
RMD
$34B
| $2.28M | ﹤0.01% |
+29,620
| New | +$2.27M |
|
|
CS
2103
DELISTED
Credit Suisse Group
CS
| $2.27M | ﹤0.01% |
143,324
-60,262
| -30% | -$915K |
|
2104
Sierra Bancorp
BSRR
$512M
| $2.26M | ﹤0.01% |
83,327
+37,983
| +84% | +$968K |
|
2105
SPDR Gold Trust
GLD
$153B
| $2.26M | ﹤0.01% |
18,599
-4,501
| -19% | -$547K |
|
2106
Radware
RDWR
$1.2B
| $2.26M | ﹤0.01% |
134,112
+119,047
| +790% | +$2.07M |
|
|
NXRT
2107
NexPoint Residential Trust
NXRT
$619M
| $2.24M | ﹤0.01% |
94,579
-32,321
| -25% | -$779K |
|
|
NUVA
2108
DELISTED
NuVasive, Inc.
NUVA
| $2.24M | ﹤0.01% |
40,421
-50,639
| -56% | -$3.35M |
|
2109
PUT
iShares MSCI Emerging Markets ETF
EEM
$31.2B
| $2.24M | ﹤0.01% |
50,000
-125,000
| -71% | -$5.5M |
|
2110
LyondellBasell Industries
LYB
$20.2B
| $2.24M | ﹤0.01% |
22,570
-10,405
| -32% | -$936K |
|
|
APTS
2111
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $2.23M | ﹤0.01% |
118,005
-270,716
| -70% | -$4.75M |
|
2112
Colliers International
CIGI
$5.34B
| $2.23M | ﹤0.01% |
+44,812
| New | +$2.33M |
|
|
FNHC
2113
DELISTED
FedNat Holding Company Common Stock
FNHC
| $2.23M | ﹤0.01% |
142,616
+122,884
| +623% | +$1.86M |
|
|
OSB
2114
DELISTED
Norbord Inc.
OSB
| $2.21M | ﹤0.01% |
58,091
-21,365
| -27% | -$741K |
|
2115
Markel Group
MKL
$22.5B
| $2.2M | ﹤0.01% |
2,058
+572
| +38% | +$591K |
|
2116
Vermilion Energy
VET
$1.87B
| $2.2M | ﹤0.01% |
+61,765
| New | +$2.03M |
|
2117
Yatra Online
YTRA
$64.6M
| $2.19M | ﹤0.01% |
+202,519
| New | +$2.2M |
|
2118
iShares MSCI South Korea ETF
EWY
$27.9B
| $2.18M | ﹤0.01% |
31,619
+26,019
| +465% | +$1.79M |
|
2119
Keysight
KEYS
$54.8B
| $2.18M | ﹤0.01% |
52,360
+24,818
| +90% | +$1.02M |
|
|
TGH
2120
DELISTED
Textainer Group Holdings limited
TGH
| $2.18M | ﹤0.01% |
+127,104
| New | +$2.03M |
|
|
RC
2121
Ready Capital
RC
$304M
| $2.18M | ﹤0.01% |
138,784
+123,256
| +794% | +$1.86M |
|
2122
National Bank Holdings
NBHC
$1.84B
| $2.17M | ﹤0.01% |
60,661
+36,245
| +148% | +$1.2M |
|
2123
Ormat Technologies
ORA
$6.36B
| $2.15M | ﹤0.01% |
35,200
+13,630
| +63% | +$786K |
|
|
SPTN
2124
DELISTED
SpartanNash
SPTN
| $2.15M | ﹤0.01% |
+81,423
| New | +$2.09M |
|
|
RRD
2125
DELISTED
RR Donnelley & Sons Co.
RRD
| $2.15M | ﹤0.01% |
208,333
-149,183
| -42% | -$1.55M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.